APG-2575
APG-2575 Study of Safety, Tolerability, PK/PD in Patients With Hematologic Malignancies
What's the purpose of the trial?
This is a multi-center, single-agent, open-label, Phase I study of APG-2575. The study consists of the dose escalation stage and the dose expansion stage.
Trial status
Accepting patients
Phase
Phase 1
Enrollment
90
Last Updated
Participating Centers
There are 2 centers participating in this trial. Enter a location below to find the closest center.
Arms / Cohorts
Explore eligibility, treatments and learn more about potential cohorts.
Accepting patients
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print this trial to share with your doctor.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.